Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma
Transient cytopenias and bone marrow hypoplasia commonly occur during treatment of CML with TKIs (tyrosine kinase inhibitors). This is usually related to the eradication of CML clones that initially compose the majority of hematopoietic cells in the bone marrow at the time of diagnosis. With continu...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2019-01-01
|
| Serie: | Case Reports in Hematology |
| Accesso online: | http://dx.doi.org/10.1155/2019/4861673 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|